Gout

The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.

Monthly Gout Reviews Leads to Significant SUA Improvements

November 13, 2022

There was also a reduction in ultrasound features of gout at the knee identified, with improvement found in 63% of the tight control group and 14% of the conventional group.

Allopurinol Use Linked to Lower Risk of First-Ever Coronary Event

November 12, 2022

Exposure to more than 100 mg was linked to significantly lower odds ratios for first-ever ACS event for women.

Pegloticase Plus Methotrexate Co-Therapy did not Impact Renal Function in Gout

November 08, 2022

Abdul Abdellatif, MD, FASN, explains the results of the MIRROR RCT trial, in which the renal function of patients with gout receiving pegloticase plus methotrexate co-therapy was evaluated.

Early Gout Onset, Tophaceous Disease in Men Linked to Risk Alleles

November 01, 2022

"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”

Allopurinol Linked to Less Mortality in Patients with Gout and Cardiovascular Disease

October 28, 2022

Investigators concluded febuxostat should still be used cautiously for patients with gout and cardiovascular diseases due to inconclusive results.

Probiotics Supplementation may Improve Symptoms of Hyperuricemia and Gout

October 13, 2022

Supplementation with probiotics was shown to improve hyperuricemia and symptoms of gout, among other inflammatory diseases.

Rheumatology Network's Top 5: October 8, 2022

October 08, 2022

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 8, 2022.

Real-World Findings Support Increased Pegloticase and Immunomodulation Co-Therapy Response Rates in Gout

October 05, 2022

“Importantly, several different immunomodulation agents may be effective for increasing treatment response rates and seem well tolerated by patients with uncontrolled gout."

Infusion Reactions and Impact of Immunomodulators in Gout

September 19, 2022

Drs Orrin M. Troum and Jeff R. Peterson discuss infusion reactions associated with pegloticase and the impact of immunomodulators when used with pegloticase in gout.

Challenges With Gout Treatment

September 19, 2022

Orrin M. Troum, MD, and Jeff R. Peterson, MD, discuss challenges with gout treatment.